首頁 > 市場調查報告書 > 製藥

痤瘡治療市場規模、佔有率和成長分析（按產品類型、劑型、給藥途徑、年齡層、分銷管道和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1895557

痤瘡治療市場規模、佔有率和成長分析（按產品類型、劑型、給藥途徑、年齡層、分銷管道和地區分類）—產業預測（2026-2033 年）

Acne Medication Market Size, Share, and Growth Analysis, By Product (Topical Retinoids, Oral Antibiotics), By Type, By Route of Administration, By Age Group, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，痤瘡治療市場規模將達到 120.3 億美元，到 2025 年將達到 130.4 億美元，到 2033 年將達到 248.6 億美元，預測期（2026-2033 年）的複合年成長率為 8.4%。

痤瘡是一種常見的皮膚疾病，影響著世界各地各個年齡層的人群，因此對痤瘡治療的需求巨大。人們對皮膚健康和外觀的日益關注，進一步推動了對有效治療方法的興趣。皮膚研究的不斷進步催生了創新的痤瘡治療方法，包括改良的外用、口服和聯合治療，從而拓寬了可供選擇的治療方案。此外，現代生活方式因素，例如壓力增大、不良飲食習慣和環境污染，與痤瘡的發生密切相關，進一步促進了人們對有效治療方法的探索。隨著消費者尋求解決這些現代因素造成的皮膚問題，痤瘡治療市場呈現出成長跡象，反映出消費者對滿足個別護膚需求的客製化解決方案的強勁需求。

痤瘡治療市場細分分析

痤瘡治療市場促進因素

對有效痤瘡治療方案日益成長的需求促使各種產品的研發，包括類視色素、異維A酸以及口服和外用抗生素。如此豐富的治療選擇顯著意識提升。隨著人們對各種痤瘡治療方案的了解不斷加深，需求也隨之成長，最終推動了痤瘡治療市場的蓬勃發展。這一趨勢凸顯了提供便利有效的治療方案對於解決痤瘡相關問題的重要性。

制約痤瘡治療市場的因素

痤瘡治療市場的成長面臨許多挑戰，其中一個主要問題是痤瘡治療的副作用。許多患者會經歷令人不適的副作用，這可能會使他們放棄並停止治療。調查顯示，相當一部分接受某些抗生素痤瘡治療（例如四環黴素和大環內酯類抗生素）的患者報告出現噁心、嘔吐和腹瀉等問題。由於這些潛在的副作用而導致的治療意願下降，不僅影響患者的依從性，也限制了痤瘡治療市場的整體擴張。

痤瘡治療市場趨勢

痤瘡治療市場正經歷顯著成長，這主要得益於消費者護膚和衛生意識的提高。這一趨勢主要受荷爾蒙變化的影響，尤其是在青少年群體中，同時各個年齡層也越來越重視整裝儀容和護膚。痤瘡的普遍存在（通常與皮脂分泌過多和生活方式因素有關）推動了對有效治療方案的需求。此外，社群媒體影響者和美妝部落格的興起進一步提升了人們對痤瘡治療的興趣，隨著消費者對護膚的了解日益加深，他們尋求積極主動的措施來改善膚質，從而推動了市場成長。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- 強生服務公司（美國）
- 葛蘭素史克公司（GSK）（英國）
- 輝瑞公司（美國）
- 艾伯維公司（美國）
- 太陽製藥工業有限公司（印度）
- 博士倫健康公司（加拿大）
- 雀巢皮膚健康有限公司（瑞士）
- 拜耳股份公司（德國）
- Viatris公司（美國）
- 梯瓦製藥工業股份有限公司（以色列）
- F. Hoffmann-La Roche Ltd（瑞士）
- LEO Pharma A/S（丹麥）
- 邁蘭公司（美國）
- Mayne Pharma Group Limited（澳洲）
- Zydus Lifesciences Limited（印度）
- Crown Laboratories（美國）
- Stryke俱樂部（美國）

結論與建議

簡介目錄

Product Code: SQMIG35I2281

Acne Medication Market size was valued at USD 12.03 Billion in 2024 and is poised to grow from USD 13.04 Billion in 2025 to USD 24.86 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

Acne remains a prevalent skin condition affecting diverse age groups globally, driving significant demand for acne medications. Heightened awareness surrounding skin health and personal appearance has fueled interest in effective treatment options. Continuous advancements in dermatological research have birthed innovative acne solutions, including enhanced topical formulations, oral treatments, and combination therapies, expanding the spectrum of available choices. Furthermore, modern lifestyle challenges-such as increased stress levels, dietary habits, and pollution-are increasingly linked to the onset of acne, further propelling the search for effective medication. As consumers seek to address skin concerns stemming from these contemporary factors, the market for acne treatments is poised for growth, reflecting a strong demand for tailored solutions that resonate with individual skincare needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Acne Medication market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Acne Medication Market Segments Analysis

Global Acne Medication Market is segmented by Product, Type, Route of Administration, Age Group, Distribution Channel and region. Based on Product, the market is segmented into Topical Retinoids, Oral Antibiotics, Oral Retinoids, Over-the-Counter (OTC) Drugs, Isotretinoin and Others. Based on Type, the market is segmented into Inflammatory Acne and Non-inflammatory Acne. Based on Route of Administration, the market is segmented into Topical, Oral and Injectable. Based on Age Group, the market is segmented into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years and 65 Years & Above. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Acne Medication Market

The increasing need for effective acne treatment solutions has led to the development of a diverse range of products, including retinoids, isotretinoins, and both oral and topical antibiotics. This broad selection of treatment options has significantly contributed to raising awareness about acne management among individuals worldwide. As more people become informed about the various available therapies for acne, it has resulted in heightened demand and, ultimately, a surge in the growth of the acne medication market. This trend underscores the importance of accessible and effective treatment alternatives in addressing the concerns related to acne.

Restraints in the Acne Medication Market

The growth of the acne medication market faces significant challenges stemming from various factors, with one of the primary concerns being the adverse effects linked to acne treatment medications. Many patients experience unpleasant side effects, which can discourage them from adhering to prescribed treatment regimens. Research indicates that a notable percentage of individuals using certain antibiotics for acne management, such as tetracycline and macrolides, report issues like nausea, vomiting, or diarrhea. This hesitation to pursue treatment due to potential side effects not only affects patient compliance but also limits the overall expansion of the acne medication market.

Market Trends of the Acne Medication Market

The acne medication market is witnessing a notable surge, fueled by a growing awareness of skincare and hygiene among consumers. This trend is largely attributed to shifting hormone levels, particularly among teenagers, and a heightened focus on personal grooming and skincare routines across all age groups. The prevalence of acne, often linked to excessive oil production and lifestyle factors, has prompted increased demand for effective treatment solutions. Furthermore, the rise of social media influencers and beauty blogs has intensified interest in acne remedies, contributing to a more informed consumer base seeking proactive measures to achieve clearer skin, thereby propelling market growth.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Trade Analysis
Customer & Buying Criteria Analysis

Global Acne Medication Market Size by Product & CAGR (2026-2033)

Market Overview
Topical Retinoids
Oral Antibiotics
Oral Retinoids
Over-the-Counter (OTC) Drugs
Isotretinoin
Others

Global Acne Medication Market Size by Type & CAGR (2026-2033)

Market Overview
Inflammatory Acne
Non-inflammatory Acne

Global Acne Medication Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Topical
Oral
Injectable

Global Acne Medication Market Size by Age Group & CAGR (2026-2033)

Market Overview
10 to 17 Years
18 to 44 Years
45 to 64 Years
65 Years & Above

Global Acne Medication Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Global Acne Medication Market Size & CAGR (2026-2033)

North America (Product, Type, Route of Administration, Age Group, Distribution Channel)
- US
- Canada
Europe (Product, Type, Route of Administration, Age Group, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type, Route of Administration, Age Group, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type, Route of Administration, Age Group, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type, Route of Administration, Age Group, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Johnson & Johnson Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (GSK) (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch Health Companies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nestle Skin Health S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LEO Pharma A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mayne Pharma Group Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zydus Lifesciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crown Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryke Club (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments